mounjaro tirzepatide manufacturer company Lilly's weight-loss drug coming to UK after pen cleared Weight loss drug lawsuit: Mounjaro

Kovesdy received consulting fees from Abbott, Akebia, Ardelyx, Astra Zeneca, Bayer, Boehringer Ingelheim, Cara Therapeutics, CSL Behring, CSL Vifor, GSK, Pharmacosmos, ProKidney, Renibus and Takeda

However, since tirzepatide is a newer medication, there is still ongoing research to determine its long-term safety and side effects

Chen K, Marsh BC, Cowan M, Al'Joboori YD, Gigout S, Smith CC, et al

In some cases, the benefits of weight loss may outweigh temporary worsening of bowel symptoms, but this decision should always be made collaboratively with your healthcare team, taking into account your individual circumstances and quality of life